Acceleration of α-synuclein aggregation by exosomes

Journal of Biological Chemistry

Volumn 290, Issue 5, 2015, Pages 2969-2982

  Marie, Grey ^a   Dunning, Christopher J ^a   Gaspar, Ricardo ^a   Grey, Carl ^a   Brundin, Patrik ^a,b   Sparr, Emma ^a   Linse, Sara ^a  

^a LUND UNIVERSITY   (Sweden)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CELLS; ELECTROPHORESIS; LIPIDS; MASS SPECTROMETRY; PHOSPHOLIPIDS; PROTEINS; TRANSMISSION ELECTRON MICROSCOPY;

AGGREGATION KINETICS; CATALYTIC ENVIRONMENT; CRYO-TRANSMISSION ELECTRON MICROSCOPY; EXTRACELLULAR SPACE; NEUROLOGICAL DISEASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; WESTERN-BLOT ANALYSIS;

CYTOLOGY;

ALPHA SYNUCLEIN; CELL PROTEIN; FLOTILLIN 1; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; LIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROTEIN ALIX; THIOFLAVINE; UNCLASSIFIED DRUG; LIPOSOME;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL ISOLATION; CELL VACUOLE; CONCENTRATION (PARAMETERS); EXOSOME; FLUORESCENCE ANALYSIS; MASS SPECTROMETRY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; HUMAN; METABOLISM; PARKINSON DISEASE;

ALPHA-SYNUCLEIN; EXOSOMES; G(M1) GANGLIOSIDE; G(M2) GANGLIOSIDE; G(M3) GANGLIOSIDE; HUMANS; PARKINSON DISEASE; PHOSPHOLIPIDS; UNILAMELLAR LIPOSOMES;

EID: 84921915868     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.585703     Document Type: Article

References (85)

1. Chivet, M., Hemming, F., Pernet-Gallay, K., Fraboulet, S., and Sadoul, R. (2012) Emerging role of neuronal exosomes in the central nervous system. Front. Physiol. 3, 145
2. Bonini, N. M., and Giasson, B. I. (2005) Snaring the function of α-synuclein. Cell 123, 359-361
3. Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., and Lee, V. M. (2000) Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. neurosci. 20, 3214-3220
4. Cremades, N., Cohen, S. I., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., Bertoncini, C. W., Wood, N. W., Knowles, T. P., Dobson, C. M., and Klenerman, D. (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149, 1048-1059
5. Schapira, A. H. (2009) Neurobiology and treatment of Parkinson's disease. Trends Pharmacol. Sci. 30, 41-47
6. Graham, J. M., and Sagar, H. J. (1999) A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Movement Disorders 14, 10-20
7. Halliday, G. M., Holton, J. L., Revesz, T., and Dickson, D. W. (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 122, 187-204
8. Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M. I., Griffiths, F. M., Shepherd, C. E., and Double, K. L. (2005) α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain 128, 2654-2664
9. Harrower, T. P., Michell, A. W., and Barker, R. A. (2005) Lewy bodies in Parkinson's disease: protectors or perpetrators? Exp. Neurol. 195, 1-6
10. Wakabayashi, K., Tanji, K., Mori, F., and Takahashi, H. (2007) The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of α-synuclein aggregates. Neuropathology 27, 494-506
11. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., Tzitzilonis, C., Soragni, A., Jessberger, S., Mira, H., Consiglio, A., Pham, E., Masliah, E., Gage, F. H., and Riek, R. (2011) In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl. Sci. Acad. U.S.A. 108, 4194-4199
12. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511
13. Lashuel, H. A., Overk, C. R., Oueslati, A., and Masliah, E. (2013) The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38-48
14. Chandra, S., Chen, X., Rizo, J., Jahn, R., and Südhof, T. C. (2003) A broken α-helix in folded α-synuclein. J. Biol. Chem. 278, 15313-15318
15. Eliezer, D., Kutluay, E., Bussell, R., Jr., and Browne, G. (2001) Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073
16. Bussell, R., Jr., and Eliezer, D. (2003) A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329, 763-778
17. Robotta, M., Braun, P., van Rooijen, B., Subramaniam, V., Huber, M., and Drescher, M. (2011) Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound α-synuclein. Chem. Phys. Chem. 12, 267-269
18. Uversky, V. N. (2007) Neuropathology, biochemistry, and biophysics of α-synuclein aggregation. J. Neurochem. 103, 17-37
19. Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., Waucquier, N., Defebvre, L., Amouyel, P., Farrer, M., and Destée, A. (2004) α-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169
20. Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schöls, L., and Riess, O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108
21. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047
22. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M. R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn-Hardy, K. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302, 841
23. Zarranz, J. J., Alegre, J., Gómez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Muñoz, D. G., and de Yebenes, J. G. (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173
24. Angot, E., Steiner, J. A., Hansen, C., Li, J. Y., and Brundin, P. (2010) Are synucleinopathies prion-like disorders? Lancet Neurol. 9, 1128-1138
25. Dunning, C. J., George, S., and Brundin, P. (2013) What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease? Prion 7, 92-97
26. Ximerakis, M., Pampalakis, G., Roumeliotis, T. I., Sykioti, V. S., Garbis, S. D., Stefanis, L., Sotiropoulou, G., and Vekrellis, K. (2014) Resistance of naturally secreted α-synuclein to proteolysis. FASEB J. 28, 3146-3158
27. Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., and Vekrellis, K. (2010) Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci. 30, 6838-6851
28. Bellingham, S. A., Guo, B. B., Coleman, B. M., and Hill, A. F. (2012) Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front. Physiol. 3, 124
29. Dunning, C. J., Reyes, J. F., Steiner, J. A., and Brundin, P. (2012) Can Parkinson's disease pathology be propagated from one neuron to another? Prog. Neurobiol. 97, 205-219
30. Chang, C., Lang, H., Geng, N., Wang, J., Li, N., and Wang, X. (2013) Exosomes of BV-2 cells induced by α-synuclein: important mediator of neurodegeneration in PD. Neurosci. Lett. 548, 190-195
31. Chivet, M., Javalet, C., Hemming, F., Pernet-Gallay, K., Laulagnier, K., Fraboulet, S., and Sadoul, R. (2013) Exosomes as a novel way of interneuronal communication. Biochem. Soc. Trans. 41, 241-244
32. Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal-Getkin, O., Winslow, A. R., Zhu, L., Vanderburg, C. R., and McLean, P. J. (2012) Exosomal cell-to-cell transmission of α synuclein oligomers. Mol. Neurodegener. 7, 42
33. Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J., and Cooper, J. M. (2011) Lysosomal dysfunction increases exosome-mediated α-synuclein release and transmission. Neurobiol. Dis. 42, 360-367
34. Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J. M., Rodrigo-Angulo, M., Gille, G., Funk, R. H., and Reichmann, H. (2012) Environmental toxins trigger PD-like progression via increased α-synuclein release from enteric neurons in mice. Sci. Rep. 2, 898
35. Buell, A. K., Galvagnion, C., Gaspar, R., Sparr, E., Vendruscolo, M., Knowles, T. P., Linse, S., and Dobson, C. M. (2014) Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation. Proc. Natl. Acad. Sci. U.S.A. 111, 7671-7676
36. Grey, M., Linse, S., Nilsson, H., Brundin, P., Sparr E. (2011) Membrane interaction of α-synuclein in different aggregation states. J. Parkinsons Dis. 1, 359-371
37. Hansen, C., Angot, E., Bergström, A. L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., Li, J. Y., and Brundin, P. (2011) α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest. 121, 715-725
38. Théry, C., Amigorena, S., Raposo, G., and Clayton, A. (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006 Chapter 3, Unit 3.22
39. Lee, B. R., and Kamitani, T. (2011) Improved immunodetection of endogenous α-synuclein. PLoS ONE 6, e23939
40. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
41. Ejlerskov, P., Rasmussen, I., Nielsen, T. T., Bergström, A. L., Tohyama, Y., Jensen, P. H., and Vilhardt, F. (2013) Tubulin polymerization-promoting protein (TPPP/p25α) promotes unconventional secretion of α-synuclein through exophagy by impairing autophagosome-lysosome fusion. J. Biol. Chem. 288, 17313-17335
42. Théry, C. (2011) Exosomes: secreted vesicles and intercellular communications. F1000 Biol. Rep. 3, 15
43. Jaspard, F., Nadi, M., and Rouane, A. (2003) Dielectric properties of blood: an investigation of haematocrit dependence. Physiol. Meas. 24, 137-147
44. Seelert, H., Poetsch, A., Dencher, N. A., Engel, A., Stahlberg, H., and Müller, D. J. (2000) Structural biology. Proton-powered turbine of a plant motor. Nature 405, 418-419
45. Hellstrand, E., Grey, M., Ainalem, M. L., Ankner, J., Forsyth, V. T., Fragneto, G., Haertlein, M., Dauvergne, M. T., Nilsson, H., Brundin, P., Linse, S., Nylander, T., and Sparr, E. (2013) Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. ACS Chem. Neurosci. 4, 1339-1351
46. Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110
47. Fauvet, B., Mbefo, M. K., Fares, M. B., Desobry, C., Michael, S., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., Eliezer, D., Moore, D. J., Schneider, B., Aebischer, P., El-Agnaf, O. M., Masliah, E., and Lashuel, H. A. (2012) α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. 287, 15345-15364
48. Giehm, L., and Otzen, D. E. (2010) Strategies to increase the reproducibility of protein fibrillization in plate reader assays. Anal. Biochem. 400, 270-281
49. Rabe, M., Soragni, A., Reynolds, N. P., Verdes, D., Liverani, E., Riek, R., and Seeger, S. (2013) On-surface aggregation of α-synuclein at nanomolar concentrations results in two distinct growth mechanisms. ACS Chem. Neurosci. 4, 408-417
50. Biancalana, M., and Koide, S. (2010) Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 1804, 1405-1412
51. Hellstrand, E., Boland, B., Walsh, D. M., and Linse, S. (2010) Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem. Neurosci. 1, 13-18
52. Cohen, S. I., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. (2013) Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. U.S.A. 110, 9758-9763
53. Olofsson, G., and Sparr, E. (2013) Ionization constants pKa of cardiolipin. PLoS ONE 8, e73040
54. Rouser, G., Fkeischer, S., and Yamamoto, A. (1970) Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5, 494-496
55. Hellstrand, E., Nowacka, A., Topgaard, D., Linse, S., and Sparr, E. (2013) Membrane lipid co-aggregation with α-synuclein fibrils. PLoS ONE 8, e77235
56. Kucerka, N., Tristram-Nagle, S., and Nagle, J. F. (2005) Structure of fully hydrated fluid phase lipid bilayers with monounsaturated chains. J. Membr. Biol. 208, 193-202
57. Martinez, Z., Zhu, M., Han, S., and Fink, A. L. (2007) GM1 specifically interacts with α-synuclein and inhibits fibrillation. Biochemistry 46, 1868-1877
58. Uversky, V. N., Li, J., and Fink, A. L. (2001) Evidence for a partially folded intermediate in α-synuclein fibril formation. J. Biol. Chem. 276, 10737-10744
59. Trexler, A. J., and Rhoades, E. (2009) α-Synuclein binds large unilamellar vesicles as an extended helix. Biochemistry 48, 2304-2306
60. Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Dawson, K. A., and Linse, S. (2010) Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem. Neurosci. 1, 279-287
61. Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., and Anandatheerthavarada, H. K. (2008) Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089-9100
62. Scott, C. C., and Gruenberg, J. (2011) Ion flux and the function of endosomes and lysosomes: pH is just the start. BioEssays 33, 103-110
63. Cole, N. B., Dieuliis, D., Leo, P., Mitchell, D. C., and Nussbaum, R. L. (2008) Mitochondrial translocation of α-synuclein is promoted by intracellular acidification. Exp. Cell Res. 314, 2076-2089
64. Svensson, K. J., Christianson, H. C., Wittrup, A., Bourseau-Guilmain, E., Lindqvist, E., Svensson, L. M., Mörgelin, M., and Belting, M. (2013) Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem. 288, 17713-17724
65. Middleton, E. R., and Rhoades, E. (2010) Effects of curvature and composition on α-synuclein binding to lipid vesicles. Biophys. J. 99, 2279-2288
66. Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L., Zhang, J., Gardner, B., Wakabayashi, J., Sesaki, H., Cheng, Y., Finkbeiner, S., Nussbaum, R. L., Masliah, E., and Edwards, R. H. (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein α-synuclein. J. Biol. Chem. 286, 20710-20726
67. Stöckl, M., Fischer, P., Wanker, E., and Herrmann, A. (2008) α-Synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J. Mol. Biol. 375, 1394-1404
68. Futerman, A. H., and Hannun, Y. A. (2004) The complex life of simple sphingolipids. EMBO Rep. 5, 777-782
69. Hoshino, T., Mahmood, M. I., Mori, K., and Matsuzaki, K. (2013) Binding and aggregation mechanism of amyloid β-peptides onto the GM1 gangli-oside- containing lipid membrane. J. Phys. Chem. B 117, 8085-8094
70. Sani, M. A., Gehman, J. D., and Separovic, F. (2011) Lipid matrix plays a role in Aβ fibril kinetics and morphology. FEBS Lett. 585, 749-754
71. Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., and Matsuzaki, K. (2008) Formation of toxic Aβ (1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Aβ (1-40) fibrils. J. Mol. Biol. 382, 1066-1074
72. Linse, S., Cabaleiro-Lago, C., Xue, W. F., Lynch, I., Lindman, S., Thulin, E., Radford, S. E., and Dawson, K. A. (2007) Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. U.S.A. 104, 8691-8696
73. Pfefferkorn, C. M., Heinrich, F., Sodt, A. J., Maltsev, A. S., Pastor, R. W., and Lee, J. C. (2012) Depth of α-synuclein in a bilayer determined by fluorescence, neutron reflectometry, and computation. Biophys. J. 102, 613-621
74. Arosio, P., Cukalevski, R., Frohm, B., Knowles, T. P., and Linse, S. (2014) Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. J. Am. Chem. Soc. 136, 219-225
75. Meisl, G., Yang, X., Hellstrand, E., Frohm, B., Kirkegaard, J. B., Cohen, S. I., Dobson, C. M., Linse, S., and Knowles, T. P. (2014) Differences in nucleation behaviour underlie the contrasting aggregation pathways of the Aβ40 and Aβ42 peptide. Proc. Natl. Sci. Acad. U.S.A. 111, 9384-9389
76. Yanagisawa, K., Odaka, A., Suzuki, N., and Ihara, Y. (1995) GM1 ganglioside-bound amyloid β-protein (A β): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066
77. Ariga, T., McDonald, M. P., and Yu, R. K. (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review. J. Lipid Res. 49, 1157-1175
78. Hong, S., Ostaszewski, B. L., Yang, T., O'Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., and Selkoe, D. J. (2014) Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 82, 308-319
79. Kakio, A., Nishimoto, S. I., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276, 24985-24990
80. Matsuzaki, K., Kato, K., and Yanagisawa, K. (2010) Aβ polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801, 868-877
81. Vingtdeux, V., Sergeant, N., and Buée, L. (2012) Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease. Front. Physiol. 3, 229
82. Keilani, S., Lun, Y., Stevens, A. C., Williams, H. N., Sjoberg, E. R., Khanna, R., Valenzano, K. J., Checler, F., Buxbaum, J. D., Yanagisawa, K., Lockhart, D. J., Wustman, B. A., and Gandy, S. (2012) Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide. J. Neurosci. 32, 5223-5236
83. Dehay, B., Martinez-Vicente, M., Ramirez, A., Perier, C., Klein, C., Vila, M., and Bezard, E. (2012) Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 8, 1389-1391
84. Dehay, B., Martinez-Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., and Bezard, E. (2013) Lysosomal impairment in Parkinson's disease. Mov. Disord. 28, 725-732
85. Michel, C. H., Kumar, S., Pinotsi, D., Tunnacliffe, A., St George-Hyslop, P., Mandelkow, E., Mandelkow, E. M., Kaminski, C. F., and Kaminski Schierle, G. S. (2014) Extracellular monomeric Tau is sufficient to initiate the spread of Tau pathology. J. Biol. Chem. 289, 956-967